{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-042024","form_type":"8-K","ticker":"RLMD","cik":"0001553643","company_name":"RELMADA THERAPEUTICS, INC.","filed_at":"2025-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.739347+00:00","generated_at":"2026-05-21T23:35:47.743460+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Relmada Therapeutics dismisses Marcum, appoints CBIZ CPAs as auditor after CBIZ acquisition of Marcum's attest business","bullets":["Marcum dismissed as independent auditor on May 8, 2025, following CBIZ CPAs' Nov 1, 2024 acquisition of Marcum's attest business.","CBIZ CPAs engaged as new auditor for fiscal year ending Dec 31, 2025; audit committee approved both actions.","Marcum's reports for 2024 and 2023 contained an explanatory paragraph about substantial doubt as a going concern.","No disagreements or reportable events occurred between Relmada and Marcum during the relevant periods.","Marcum furnished a letter to the SEC agreeing with the disclosures in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-042024","json":"https://secwatch.observer/filing/0001213900-25-042024.json","markdown":"https://secwatch.observer/filing/0001213900-25-042024.md","text":"https://secwatch.observer/filing/0001213900-25-042024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025042024/0001213900-25-042024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025042024/ea024173301-8k_relmada.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T23:35:47.743460+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9c3bfd87db1122ec19ca050abf5bf7a06837d62c","claim":"RELMADA THERAPEUTICS, INC. engaged CBIZ CPAs P.C. as its auditor.","evidence_excerpt":"On May 8, 2025, with the approval of the Company’s audit committee, CBIZ CPAs was engaged as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2025.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025042024/0001213900-25-042024-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"CBIZ CPAs P.C."}],"fact_type":"auditor_change"},{"claim_id":"ccf6f57732e76eb721c08a418189f8da5bc47087","claim":"RELMADA THERAPEUTICS, INC. dismissed Marcum LLP as its auditor.","evidence_excerpt":"On May 8, 2025, the Company dismissed Marcum as the Company’s independent registered public accounting firm as a result of such acquisition, and the Company’s audit committee approved the dismissal.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025042024/0001213900-25-042024-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"Marcum LLP"},{"label":"Successor","value":"CBIZ CPAs P.C."}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}